Web Results

www.prnewswire.com/news-releases/athenex-announces-the-addition-of-simon-pedder-phd-and-raymond-yeung-msc-mba-to-its-global-leadership-team-300217379.html

Feb 9, 2016 ... 9, 2016 /PRNewswire/ -- Athenex, Inc. announced today that Simon Pedder, PhD, has joined Athenex as Vice President of Corporate Strategy ...

www.linkedin.com/in/simon-pedder-632240b

View Simon Pedder's full profile. It's free! Your colleagues, classmates, and 500 million other professionals are on LinkedIn. View Simon's Full Profile ...

www.xconomy.com/wisconsin/2015/06/16/cellectar-biosciences-appoints-new-ceo-amid-recent-turmoil

Jun 16, 2015 ... Seasoned drug and device industry executive Jim Caruso is taking over for Simon Pedder, who resigned his positions as Cellectar CEO, ...

www.crunchbase.com/person/simon-pedder-2

Dr. Simon Pedder, Ph.D., served as the Founder and Chief Executive Officer of Chelsea Therapeutics International Ltd. from April 2004 until July 2012.

www.athenex.com/our-team/our-leadership-team

Simon Pedder, PhD. Chief Business and Strategy Officer, Proprietary Products. Simon has a long career in drug development including recent leadership roles ...

www.ca4.uscourts.gov/Opinions/Published/132370.P.pdf

Dec 10, 2014 ... GOODRICH & ROASATI, Palo Alto, California, for Appellees Chelsea. Therapeutics International, Ltd., Simon Pedder, and William D.

atlanticresearchgroup.com/about/board

Meet the Atlantic Research Group's Board of Directors.

www.law360.com/articles/801453/chelsea-therapeutics-settles-investor-class-action-for-5-5m

May 27, 2016 ... Zak sued Chelsea — which is now owned by the Danish company H. Lundbeck A/S — its former president and CEO Simon Pedder, and former ...

investor.cellectar.com/releasedetail.cfm?releaseid=833378

Feb 11, 2014 ... ... eye toward taking the necessary steps to begin rebuilding shareholder value,” commented Dr. Simon Pedder, acting chief executive officer.